Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Emanuela Troiani"'
Autor:
Piero Galieni, Sadia Falcioni, Emanuela Troiani, Paola Picardi, Catia Bigazzi, Denise Maravalle, Federica De Giorgi, Roberta Taborro, Stefano Angelini
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/785f823a54b34699be3536cf9efe502b
Autor:
Denise Maravalle, Patrizia Caraffa, Mario Angelini, Valerio Pezzoni, Alessia Dalsass, Serena Mazzotta, Sadia Falcioni, Paola Picardi, Stefano Angelini, Miriana Ruggieri, Piero Galieni, Emanuela Troiani, Fosco Travaglini, Davide Vagnoni, Catia Bigazzi, Elisa Camaioni, Francesca Mestichelli
Publikováno v:
British Journal of Haematology. 193:542-550
The Revised International Staging System (R-ISS) stratifies patients affected by Multiple Myeloma (MM) into three distinct risk groups: R-ISS I [ISS Stage I, Standard-Risk cytogenetics and normal Lactase DeHydrogenase (LDH)], R-ISS III (ISS stage III
Autor:
Francesca Mestichelli, Valerio Pezzoni, Silvia Ferretti, Mario Angelini, Sabrina Mei, Alessia Dalsass, Elisa Camaioni, Emanuela Troiani, Stefano Angelini, Piero Galieni, Fosco Travaglini
Publikováno v:
British Journal of Haematology. 183:152-155
Autor:
Stefano Angelini, Piero Galieni, Francesca Mestichelli, Fosco Travaglini, Mario Angelini, Patrizia Caraffa, Catia Bigazzi, Silvia Ferretti, Serena Mazzotta, Valerio Pezzoni, Miriana Ruggieri, Emanuela Troiani, Sadia Falcioni, Alessia Dalsass
Publikováno v:
Bone Marrow Transplantation. 53:91-93
Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation
Autor:
Mario Angelini, Sadia Falcioni, Miriana Ruggieri, Valerio Pezzoni, Francesca Mestichelli, Alessia Dalsass, Davide Vagnoni, Catia Bigazzi, Emanuela Troiani, Annalisa Natale, Serena Mazzotta, Piero Galieni, Fosco Travaglini, Silvia Ferretti, Stefano Angelini
Publikováno v:
British Journal of Haematology. 170:523-531
Detection of circulating plasma cells (PCs) in multiple myeloma (MM) patients is a well-known prognostic factor. We evaluated circulating PCs by flow cytometry (FC) in 104 patients with active MM at diagnosis by gating on CD38(+) CD45(-) cells and ex
Autor:
Catia Bigazzi, Davide Vagnoni, Valerio Pezzoni, Piero Galieni, Alessia Dalsass, Emanuela Troiani, Francesca Mestichelli, Immacolata Attolico, Mario Angelini, Miriana Ruggieri, Massimo Catarini, Stefano Angelini, Giancarlo Discepoli, Ilaria Scortechini, Paola Gaspari, Francesco Alesiani, Sadia Falcioni
Publikováno v:
European Journal of Haematology. 91:10-19
Deletions of the long arm of chromosome 6 are known to occur at relatively low frequency (3-6%) in chronic lymphocytic leukemia (CLL), and they are more frequently observed in 6q21. Few data have been reported regarding other bands on 6q involved by
Autor:
Pietro Leoni, Giancarlo Discepoli, Emanuela Troiani, M Montanari, Antonella Poloni, Attilio Olivieri, Debora Capelli, Massimo Offidani
Publikováno v:
Experimental Hematology. 35:1074-1082
Objective We evaluated the feasibility of a new regimen in elderly patients with acute myeloid leukemia (AML). The main end points were overall response rate (ORR) and toxicity; secondary end points were feasibility of peripheral blood stem cells (PB
Autor:
Antonella Poloni, Emanuela Troiani, Moira Lucesole, Guido Gini, Pietro Leoni, Debora Capelli, M Montanari, Attilio Olivieri, Marco Candela, Ilaria Scortechini
Publikováno v:
Biology of Blood and Marrow Transplantation. 11:627-636
From 1999 to 2002, 20 patients with aggressive non-Hodgkin lymphoma, among 28 who failed autologous peripheral blood progenitor cell transplantation, were rescued with cyclophosphamide, hydroxydaunomycin, Oncovin (vincristine), and prednisone (CHOP)/
Autor:
Sadia Falcioni, Stefano Angelini, Mario Angelini, Alessia Dalsass, Valerio Pezzoni, Davide Vagnoni, Annalisa Natale, Catia Bigazzi, Miriana Ruggieri, Emanuela Troiani, Francesca Mestichelli, Piero Galieni, Fosco Travaglini, Serena Mazzotta
Publikováno v:
Blood. 124:3353-3353
Multiple Myeloma (MM) is a clonal B-cell disorder characterized by accumulation of malignant plasma cells (PCs) in the bone marrow (BM). Circulating PCs can be detected in the peripheral blood of a significant proportion of patients with MM and their